Status:
COMPLETED
Impact of Heart Failure Center Program on Cardiac Outcomes in Patients With Heart Failure
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Death
Congestive Heart Failure
Eligibility:
All Genders
20-80 years
Brief Summary
Congestive heart failure (CHF) is a major public health problem worldwide. CHF carries a devastating prognosis, which resembles that of some types of malignant cancer. Despite substantial improvements...
Detailed Description
Congestive heart failure (CHF) is a major public health problem world-wide. CHF carries a devastating prognosis which resembles that of some types of malignant cancer. Its incidence rises steadily fro...
Eligibility Criteria
Inclusion
- patients hospitalized due to acute cardiogenic pulmonary edema documented on chest x-ray and
- left ventricular ejection fraction (LVEF) \< 40% as documented by echocardiography; and
- aged \> 20 and \< 80 years.
Exclusion
- the presence of systemic diseases such as hypothyroidism, decompensated liver cirrhosis, and systemic lupus erythematosus;
- a disorder other than HF that might compromise survival within 6 months;
- having implanted materials that could interfere with the bioimpedance analysis,
- being bed-ridden for \> 3 months and/or unable to stand alone;
- having serum creatinine of \> 5 mg/dl or nephritic syndrome;
- having active cellulites, severe varicose veins, lymphedema or deep vein thrombosis over lower extremity;
- undergoing dialysis within 2 weeks;
- having severe coronary artery disease without complete revascularization therapy; and
- being pregnant.
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2012
Estimated Enrollment :
470 Patients enrolled
Trial Details
Trial ID
NCT01416285
Start Date
June 1 2010
End Date
May 30 2012
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Keelung, Taiwan, 402